new post
StocksRunner logo
mail
search
 
menu
 
Teva Pharma
$31.74
+0.63%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

TEVA Stock Analysis & IQ Rating | Teva Pharma

 
 
 

TEVATEVA Badge

 

Teva Pharma

$31.74

 
+$0.20 | +0.63%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$31.99
 
 
MKT CAP
$36.36B
 
52W Low
$12.47
 
 
VOL
$3.79M
 
P/E Ratio
51.9
 
 
AVG VOL
$10.98M
 
RSI
85.08
 
 
TREND
Uptrend
 
 
 

BQ Stock IQ

 
lock  Login to see Teva Pharma (TEVA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

TEVA Target Price

 
 
 

Strengths

 
 

TEVA Rewards

 Earnings are forecast to grow

TEVA Rewards

 Upgraded on attractively valued

TEVA Rewards

 Trading below its fair value

TEVA Rewards

 Investors confidence is positive

 
 

TEVA Price Performance

 
 

$26.32   (+20.59%)

$20.2   (+57.13%)

$15.69   (+102.29%)

$20.94   (+51.58%)

 
 
1year
6month
3month
1month
 

TEVA Risk Level

 
 

TEVA has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
TEVA Risk Level
Low
LOW
HIGH
 

TEVA Analysts Opinion

 

TEVA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

TEVA Earnings Sentiment

 Above analyst estimates

TEVA Earnings Sentiment

 Reported a strong earnings

TEVA Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

 

TEVA Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

TEVA Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

 

TEVA Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

TEVA Future Sentiment

 Earnings are forecast to grow

TEVA Future Sentiment

 Trading below its fair value

 
 

TEVA Analysts Opinion

TEVA Analysts opinion is positive and also has improved from the past 3 months

 

TEVA Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
38%
100%
 

TEVA Street Sentiment 

TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

TEVA Performance Sentiment

 
Sentiments overview associated with TEVA events and the stock performance.
 
 
78%
19%
Positive
Negative
29 out of 37
events present
7 out of 37
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$31.54
 
Resistance
Price
 
$24.12
 
 
Current Price Range
 
$31.54
 
 
Show methods +
 
 
TEVA Latest Analysis +
 
 
FAQ About TEVA Stock Insights
 

What is TEVA current stock price?

What are TEVA stock strengths?

What is TEVA Risk Level?

What is TEVA market cap and volume?

What is TEVA current Stock IQ?

Should I buy TEVA stock right now?

Is TEVA a Strong Buy right now?

What does a 'Strong Buy' rating mean for TEVA?

What does a 'Strong Sell' rating mean for TEVA?

What factors influence TEVA's Stock IQ?

 
 
StocksRunner

Explore our TEVA Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored TEVA Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our TEVA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

TEVA TEVA Badge

 

Teva Pharma

 
 

Current Price

 

$31.74

 
+$0.20 | +0.63%
 
 
52W High
$31.99
 
 
MKT CAP
$36.36B
 
52W Low
$12.47
 
 
VOL
$3.79M
 
P/E Ratio
51.9
 
 
AVG VOL
$10.98M
 
RSI
85.08
 
 
TREND
Uptrend
 
 
 
Set Alerts
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

TEVA Rewards

 Earnings are forecast to grow

TEVA Rewards

 Upgraded on attractively valued

TEVA Rewards

 Trading below its fair value

TEVA Rewards

 Investors confidence is positive

 
 
 
 
user
 
 
 
 

TEVA Price Performance

 
 

$26.32   (+20.59%)

$20.2   (+57.13%)

$15.69   (+102.29%)

$20.94   (+51.58%)

 
 
1year
6month
3month
1month
 

TEVA Analysts Opinion

 

TEVA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

TEVA Earnings Sentiment

 Above analyst estimates

TEVA Earnings Sentiment

 Reported a strong earnings

TEVA Earnings Sentiment

 Revenue increase YoY

 
 

Rating

×
 

Rating

 

TEVA Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 

TEVA Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

 

TEVA Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

TEVA Future Sentiment

 Earnings are forecast to grow

TEVA Future Sentiment

 Trading below its fair value

 
 

TEVA Analysts Opinion

TEVA Analysts opinion is positive and also has improved from the past 3 months

 

TEVA Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
38%
100%
 

TEVA Street Sentiment 

TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

TEVA Risk Level

 
 

TEVA has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
TEVA Risk Level
Low
LOW
HIGH
 
TEVA Performance Sentiment
 
Sentiments overview associated with TEVA events and the stock performance.
 
 
78%
19%
Positive
Negative
29 out of 37
events present
7 out of 37
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$31.54
 
Resistance
Price
 
$24.12
 
 
Current Price Range
 
$31.54
 
 
Show methods +
 
 
 
 
 
 

TEVA Stock IQ

 
 
 
lock  Login to unlock Teva Pharma (TEVA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

TEVA Latest Analysis

 
 
 

S&P Global Ratings Upgrades Teva to BB Amid Strong Execution of Pivot to Growth Strategy. Moodys Ratings Agency Revises Outlook to Positive. TEL AVIV Israel Dec. 24 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that S&.P Global Ratings (S&.P) has upgraded Tevas long-term issuer credit rating to BB from BB with a stable outlook and that Moodys Ratings Agency (Moodys) affirmed Tevas B1a rating and revised Tevas outlook to positive from sta

 

Today

$31.74 | +0.63%
 
Earnings
Potential
Rating

Teva Pharmaceuticals: Why Its Time To Cash Out (Rating Downgrade).

 

Tue Dec 23, 2025

$31.54 | +1.06%
 
Activity

Piper Sandler Maintains Teva Pharmaceutical Industries Limited - Depositary Receipt (TEVA) Overweight Recommendation. Fintel reports that on December 22 2025 Piper Sandler maintained coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt (NYSE:TEVA) with a Overweight recommendation. Analyst Price Forecast Suggests 99.66% Downside

 

Tue Dec 23, 2025

$31.54 | +1.06%
 
Momentum
Rating

Teva upgraded to BB by S&P on deleveraging progress.

 

Mon Dec 22, 2025

$31.21 | +2.83%
 
Rating

Alvotech Teva Secure United States License Entry Date For Eylea Biosimilar AVT06 . (RTTNews) - Alvotech (ALVO) and Teva Pharmaceutical Industries Ltd. (TEVA) have secured a United States license entry date for AVT06 the proposed biosimilar to Regenerons Eylea setting the stage for a potential fourth-quarter 2026 launch pending FDA approval.

 

Fri Dec 19, 2025

$30.35 | +0.12%
 
Activity

Insider Selling: Amir Weiss Unloads $371K Of Teva Pharmaceutical Indus Stock. Disclosed on December 18 TEVA) executed a substantial insider sell as per the latest SEC filing.United States Securities and Exchange Commission on Thursday outlined that Weiss executed a sale of 12300 shares of Monitoring the market Teva Pharmaceutical based in Israel is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of

 

Fri Dec 19, 2025

$30.35 | +0.12%
 
Activity
Activity

Alvotech Teva Secures United States License Entry Date For Eylea Biosimilar AVT06 . (RTTNews) - Alvotech (ALVO) and Teva Pharmaceutical Industries Ltd. (TEVA) have secured a United States license entry date for AVT06 the proposed biosimilar to Regenerons Eylea setting the stage for a potential fourth-quarter 2026 launch pending FDA approval.

 

Fri Dec 19, 2025

$30.35 | +0.12%
 
Activity

Alvotech and Teva Secure United States Settlement Date for AVT06 a Proposed Biosimilar to Eylea®. REYKJAVIK Iceland and TEL AVIV Israel Dec. 19 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Teva Pharmaceuticals a United States affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that they have reached a settlement and license agreement w

 

Fri Dec 19, 2025

$30.35 | +0.12%
 
Activity

Heres Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

 

Thu Dec 18, 2025

$30.32 | +0.88%
 
Potential

BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight. We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Teva Pharmaceuticals Industries Limited is one of the most undervalued stocks on our list. TheFly reported on December 9 that Bank of America Securities analyst Jason Gerberry reaffirmed a Buy rating on TEVA and raised his price target to $32.00 reflecting [….]

 

Wed Dec 17, 2025

$30.06 | -0.13%
 
Potential
Rating
 
 
 
 
 
StocksRunner

Discover TEVA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of TEVA. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our TEVA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TEVA Stock trends

TEVA Stock performance

TEVA Stock analysis

TEVA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

TEVA Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing TEVA

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing TEVA

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.